Citicoline: pharmacological and clinical review, 2022 update

This review is based on the previous one published in 2016 (Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73), incorporating 176 new references, having all the information available in the same document to facilitate the access to the inf...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista de neurologiá 2022-11, Vol.75 (s05), p.S1-S89
Hauptverfasser:	Secades, J J, Gareri, P
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Brain Injuries, Traumatic - drug therapy Cognitive Dysfunction - drug therapy Cytidine Diphosphate Choline - pharmacology Cytidine Diphosphate Choline - therapeutic use Humans Nootropic Agents - pharmacology Nootropic Agents - therapeutic use Review Stroke - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This review is based on the previous one published in 2016 (Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73), incorporating 176 new references, having all the information available in the same document to facilitate the access to the information in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.
ISSN:	1576-6578 0210-0010 1576-6578
DOI:	10.33588/rn.75S05.2022311